Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorShaheed Benazir Bhutto University Sheringal Dir Upper

About this trial

This Phase I randomized clinical trial aims to investigate the short-term effects of three commonly prescribed statins (atorvastatin, rosuvastatin, and simvastatin) at different dose levels on blood glucose homeostasis in healthy volunteers. The study will assess changes in fasting blood glucose, insulin, and C-peptide levels following two days of statin administration under controlled conditions. The research seeks to provide comparative data on the potential diabetogenic effects of these medications.

Eligibility criteria

Qualifiers

healthy volunteers

Non diabetic

blood glucose level (less than140 mg/dl)

Disqualifiers

Participants with a history of diabetes mellitus

With chronic diseases e.g heart disease, kidney disease

participants taking other medications

Trial design

Treatments tested in this trial

  • Simvastatin (10mg, 20mg, 40mg)
  • Rosuvastatin (5mg, 20mg, 40mg)
  • Atorvastatin (10mg, 20mg, 40mg)

Treatment groups

100 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Shaheed Benazir Bhutto University Sheringal Dir Upper

Lead sponsor

Khyber Medical University Peshawar

Collaborator